Continuum Advisory’s Novartis NVS Stock Holding History

Continuum Advisory's NVS Position: Q2 2026 in Review

Continuum Advisory opened a new position in Novartis (NVS) in Q2 2026: 1,421 shares worth $223K. The stake represents 0.02% of the portfolio and ranks #445 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in NVS as recently as Q1 2025.

Continuum Advisory first reported a position in NVS in Q1 2017 and has held it in 22 quarters since. The position peaked at $853K in Q2 2023. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

• Continuum Advisory held 1,421 shares of Novartis worth $223K as of Q2 2026.
• Novartis was a new Continuum Advisory position in Q2 2026.
• Novartis made up 0.02% of Continuum Advisory's portfolio in Q2 2026, its #445 holding.
• Continuum Advisory first reported a position in Novartis in Q1 2017 and has held it in 22 quarters since.
• Continuum Advisory's Novartis position peaked at $853K in Q2 2023.
• 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.